" class="no-js "lang="en-US"> Pfizer Archives - Medtech Alert
Monday, June 17, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Pfizer Announces Positive Marstacimab Results from Pivotal Phase 3 Hemophilia A and B Trial

Pfizer has announced that the pivotal Phase 3 BASIS clinical trial (NCT03938792) evaluating marstacimab has […]

Bridgewest Perth Pharma to Commercialize Sterile Injectable Drugs Under LumaCina Business Unit

Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, […]

Phase 3 Study Shows XTANDI® (enzalutamide) plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Non-Metastatic Prostate Cancer

Pfizer and Astellas Pharma have announced positive topline results from the Phase 3 EMBARK trial […]

Pfizer’s ZAVZPRET™ (zavegepant) Migraine Nasal Spray Receives FDA Approval

Pfizer has announced the US Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the […]

Pfizer Receives Potential FDA Approval for RSV Vaccine Candidate

Pfizer has announced that the US Food and Drug Administration’s (FDA) Vaccines and Related Biological […]

Vysioneer Announces Data Sharing Agreement with Pfizer to Augment Oncology Clinical Trials with Artificial Intelligence

Vysioneer, a pioneer in AI for Oncology, today announced a data-sharing agreement with Pfizer, a […]

FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib)

Pfizer has announced that the United States Food and Drug Administration (FDA) approved its supplemental […]

Ribon Therapeutics Announces $25 Million Equity Investment from Pfizer

Ribon Therapeutics, a clinical-stage biotechnology company developing therapeutics to target stress support pathways, today announced […]

Longevity Biotech Gero Entered a Research Collaboration With Pfizer to Discover Potential Targets for Fibrotic Diseases

Gero today announced that it has entered into a research collaboration with Pfizer to apply Gero’s machine-learning […]

New Partnership to Boost Research into Vaccines for Cancer

Trials into vaccines for cancer and wider diseases will accelerate after the government reached a […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more